Calf coronary arteries and cardiac veins react to anaphylaxis mediators. A new anti-allergic agent, Compound PRD-92-EA, inhibited anaphylactic reactions, suggesting its therapeutic potential.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: